Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (131-140 of 617) with videos related to

Pageof 62
Sort By:
Clinical and Molecular Hepatology|June 29, 2026
Comparison of Clinical Practice Guidelines for Chronic Hepatitis B: Natural History Classification and Treatment InitiationGi-Ae Kim, Won-Mook Choi, Gwang Hyeon Choi, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2008
Insight into alcohol-related problems and its associations with severity of alcohol consumption, mental health status, race, and level of acculturation in southern Taiwanese indigenous people with alcoholismCheng-Fang Yen, Ray C Hsiao, Richard Ries, et al.
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic ImpactJames M Paik, Linda Henry, Khalid AlNaamani, et al.
Antiviral Research|June 9, 2025
Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis CSaptarshi Bhattacharyya, Ming-Lung Yu, Phumelele Yvonne Siphepho, et al.
Viruses|April 28, 2023
Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 PandemicChi-Ming Tai, Ming-Jong Bair, Tzu-Haw Chen, et al.
Journal of Hepatology|November 17, 2006
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinomaShi-Ming Lin, Ming-Lung Yu, Chuan-Mo Lee, et al.
Diabetes Care|August 30, 2008
High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et alChia-Yen Dai, Wan-Long Chuang, Chi-Kong Ho, et al.
Journal of Gastroenterology and Hepatology|March 3, 2006
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture techniqueZu-Yau Lin, Wan-Long Chuang, Yen-Hwang Chuang, et al.
The American Journal of Gastroenterology|February 22, 2008
Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis CMing-Yen Heish, Chia-Yen Dai, Jee-Fu Huang, et al.
BMJ Open|May 16, 2015
Serological investigation to identify risk factors for post-flood infectious diseases: a longitudinal survey among people displaced by Typhoon Morakot in TaiwanChun-Yu Lin, Tun-Chieh Chen, Chia-Yen Dai, et al.
Pageof 62

Showing results (131-140 of 617) with videos related to

Sort By:
Pageof 62
Clinical and Molecular Hepatology|June 29, 2026
Comparison of Clinical Practice Guidelines for Chronic Hepatitis B: Natural History Classification and Treatment InitiationGi-Ae Kim, Won-Mook Choi, Gwang Hyeon Choi, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2008
Insight into alcohol-related problems and its associations with severity of alcohol consumption, mental health status, race, and level of acculturation in southern Taiwanese indigenous people with alcoholismCheng-Fang Yen, Ray C Hsiao, Richard Ries, et al.
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic ImpactJames M Paik, Linda Henry, Khalid AlNaamani, et al.
Antiviral Research|June 9, 2025
Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis CSaptarshi Bhattacharyya, Ming-Lung Yu, Phumelele Yvonne Siphepho, et al.
Viruses|April 28, 2023
Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 PandemicChi-Ming Tai, Ming-Jong Bair, Tzu-Haw Chen, et al.
Journal of Hepatology|November 17, 2006
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinomaShi-Ming Lin, Ming-Lung Yu, Chuan-Mo Lee, et al.
Diabetes Care|August 30, 2008
High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et alChia-Yen Dai, Wan-Long Chuang, Chi-Kong Ho, et al.
Journal of Gastroenterology and Hepatology|March 3, 2006
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture techniqueZu-Yau Lin, Wan-Long Chuang, Yen-Hwang Chuang, et al.
The American Journal of Gastroenterology|February 22, 2008
Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis CMing-Yen Heish, Chia-Yen Dai, Jee-Fu Huang, et al.
BMJ Open|May 16, 2015
Serological investigation to identify risk factors for post-flood infectious diseases: a longitudinal survey among people displaced by Typhoon Morakot in TaiwanChun-Yu Lin, Tun-Chieh Chen, Chia-Yen Dai, et al.
Pageof 62